News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
356,658 Results
Type
Article (22986)
Company Profile (141)
Press Release (333531)
Section
Business (111083)
Career Advice (930)
Deals (19288)
Drug Delivery (98)
Drug Development (54549)
Employer Resources (85)
FDA (8096)
Job Trends (8112)
News (196472)
Policy (18330)
Tag
Academia (989)
Alliances (29531)
Alzheimer's disease (641)
Approvals (8095)
Artificial intelligence (115)
Bankruptcy (178)
Best Places to Work (5859)
Biosimilars (80)
Breast cancer (107)
Cancer (959)
Cardiovascular disease (90)
Career advice (749)
Cell therapy (211)
Clinical research (45079)
Collaboration (415)
Compensation (140)
COVID-19 (1147)
C-suite (111)
Data (982)
Diabetes (136)
Diagnostics (1880)
Drug pricing (103)
Earnings (40511)
Employer resources (79)
Events (52241)
Executive appointments (377)
FDA (8583)
Funding (288)
Gene therapy (135)
GLP-1 (546)
Government (1956)
Healthcare (6641)
Infectious disease (1217)
Inflammatory bowel disease (83)
Interviews (124)
IPO (7736)
Job creations (2531)
Job search strategy (684)
Layoffs (281)
Legal (4312)
Lung cancer (141)
Lymphoma (84)
Manufacturing (174)
Medical device (2239)
Medtech (2242)
Mergers & acquisitions (11750)
Metabolic disorders (432)
Neuroscience (907)
NextGen: Class of 2025 (2620)
Non-profit (1157)
Northern California (1002)
Obesity (266)
Opinion (211)
Parkinson's disease (77)
Patents (122)
People (34864)
Phase I (14438)
Phase II (19272)
Phase III (15024)
Pipeline (487)
Policy (90)
Postmarket research (1672)
Preclinical (5264)
Radiopharmaceuticals (161)
Rare diseases (235)
Real estate (3374)
Regulatory (13099)
Research institute (1041)
Resumes & cover letters (145)
Southern California (958)
Startups (2155)
United States (9185)
Vaccines (252)
Weight loss (215)
Date
Today (7)
Last 7 days (352)
Last 30 days (1481)
Last 365 days (18834)
2025 (2546)
2024 (19041)
2023 (21217)
2022 (27735)
2021 (28561)
2020 (26543)
2019 (21529)
2018 (16823)
2017 (18358)
2016 (17294)
2015 (20260)
2014 (15950)
2013 (13750)
2012 (14742)
2011 (14968)
2010 (13763)
Location
Africa (443)
Asia (26515)
Australia (3698)
California (2333)
Canada (1029)
China (260)
Colorado (90)
Connecticut (100)
Europe (53864)
Florida (384)
Illinois (222)
Indiana (156)
Japan (96)
Maryland (333)
Massachusetts (1875)
Minnesota (126)
New Jersey (872)
New York (662)
North Carolina (470)
Northern California (1002)
Ohio (82)
Pennsylvania (522)
South America (667)
Southern California (958)
Texas (286)
Washington State (276)
356,658 Results for "stem pharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharming Group to participate in February 2025 investor conference
February 10, 2025
·
1 min read
Business
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
Stem Pharm, Inc. and Verge Genomics, announced a collaboration to develop a disease model to validate novel targets identified by Verge for Parkinson’s disease (PD).
October 10, 2023
·
3 min read
Pharming Group to participate in June 2024 investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.
June 3, 2024
·
1 min read
Pharming Group to participate in May 2024 investor conference
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of May.
May 20, 2024
·
1 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Press Releases
Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea
January 9, 2025
·
9 min read
Pharming Group to participate in April 2024 investor conferences
Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of April:.
April 3, 2024
·
1 min read
Press Releases
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
January 21, 2025
·
9 min read
Press Releases
Pharming announces public cash offer to the shareholders of Abliva AB
December 16, 2024
·
10 min read
Press Releases
Pharming announces positive topline data in pediatric clinical trial of leniolisib
December 11, 2024
·
9 min read
1 of 35,666
Next
